[HTML][HTML] Frequency of Mortality and Adverse Outcomes of COVID-19 in Hospitalized Type 2 Diabetics with a History of Sitagliptin or Metformin Use
H Raji, H Rashidi, L Moradi, F Kianizadeh… - Jundishapur Journal of …, 2024 - brieflands.com
Background: The relationship between various blood glucose-lowering treatments for type 2
diabetes mellitus (T2DM) and the mortality and complication rates of COVID-19 infection …
diabetes mellitus (T2DM) and the mortality and complication rates of COVID-19 infection …
Metformin as an activator of AMP-activated protein kinase. Known and new mechanisms of action
AM Mkrtumyan, TN Markova… - Diabetes …, 2023 - dia-endojournals.ru
Metformin, known in the medical community as the drug of first choice for type 2 diabetes
mellitus, belongs to the group of biguanides and has proven to be an effective treatment in …
mellitus, belongs to the group of biguanides and has proven to be an effective treatment in …
[PDF][PDF] Type 2 diabetes mellitus and COVID-19: A narrative review. Biomedicines 2022, 10, 2089
C Rey-Reñones, S Martinez-Torres, FM Martín-Luján… - 2022 - academia.edu
Type-2 diabetes mellitus (T2DM) is a chronic metabolic disorder. The incidence and
prevalence of patients with T2DM are increasing worldwide, even reaching epidemic values …
prevalence of patients with T2DM are increasing worldwide, even reaching epidemic values …
Acute Coronary Syndrome: Destabilization of Atherosclerotic Plaque in COVID-19 (Epidemiology, Influence on Prognosis, Pathogenesis, and Treatment)
Abstract Coronavirus disease 2019 (COVID-19) has become a major problem in the
medicine worldwide. Numerous studies have found that cardiovascular disease worsens the …
medicine worldwide. Numerous studies have found that cardiovascular disease worsens the …
Calidad de las revisiones sistemáticas de COVID-19 en personas con diabetes: una revisión sistemática
J Santos-Marques, M de Oliveira-Meneses… - Enfermería …, 2022 - Elsevier
Objetivo Investigar la calidad metodológica de las revisiones sistemáticas publicadas sobre
factores asociados con COVID-19 en personas con diabetes. Método Revisión sistemática …
factores asociados con COVID-19 en personas con diabetes. Método Revisión sistemática …
Antidiabetic Drugs in COVID-19
Diabetes mellitus (DM) has been linked to COVID-19 incidence, severity, and worse
outcomes. Antidiabetic drugs have been suggested to affect COVID-19 outcomes via several …
outcomes. Antidiabetic drugs have been suggested to affect COVID-19 outcomes via several …
[PDF][PDF] Facultad de Ciencias Medicas Carrera de Medicina
ÁFC Cedillo - 2024 - dspace.ucuenca.edu.ec
Antecedentes: en Ecuador, para el 24 de octubre de 2022 se contabilizaron 1, 01 millones
de individuos infectados y 35,908 muertes por COVID-19. A pesar del predominio de formas …
de individuos infectados y 35,908 muertes por COVID-19. A pesar del predominio de formas …
[HTML][HTML] Metformin in COVID-19: clinical trials are needed to prove its benefits
The retrospective cohort study reported by Saygili and colleagues [1] is the latest addition to
the literature on the use of metformin in patients with coronavirus disease 2019 (COVID-19) …
the literature on the use of metformin in patients with coronavirus disease 2019 (COVID-19) …
[HTML][HTML] Терапевтический потенциал применения гликлазида МВ при сочетании COVID-19 и сахарного диабета 2 типа
ДВ Беликина, ТА Некрасова, ЛГ Стронгин… - FOCUS …, 2024 - cyberleninka.ru
Известно, что больные COVID-19 с сопутствующим сахарным диабетом 2 типа и
выраженными дисгликемическими нарушениями характеризуются более тяжелым …
выраженными дисгликемическими нарушениями характеризуются более тяжелым …
[PDF][PDF] METFORMIN EFFECTIVENESS IN REDUCING MORTALITY OF COVID-19 PATIENTS WITH TYPE 2 DIABETES MELLITUS AT A TERTIARY HOSPITAL IN …
Y Zihono, H Yusmaini, U Hasanah… - Folia Medica …, 2023 - e-journal.unair.ac.id
ABSTRACT COVID-19 patients with comorbidities, such as type 2 diabetes (T2DM), have a
higher mortality rate compared to those without any comorbidities. T2DM patients usually …
higher mortality rate compared to those without any comorbidities. T2DM patients usually …